Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Mitigating HIV-Associated Premature Aging Through Cannabinoid-Mediated Anti-Inflammatory Mechanisms

Award Number: R01DA067338
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/01/2026
PERIOD OF PERFORMANCE END DATE: 06/30/2031

Group Awards By:

View Award Description

Mitigating HIV-Associated Premature Aging Through Cannabinoid-Mediated Anti-Inflammatory Mechanisms - Abstract The UNAIDS in 2023 estimated that 8.1 out of 40 million people living with HIV (PWH) globally were 50 years or older, 41% of PWH in the U.S. are at least 55 years old, and are at increased risk for chronic diseases such as cancer and premature aging. The extended lifespan, poor ART penetration of the brain, neuroviral replication, and chronic neuroinflammation in PWH can all lead to early onset of age-related neurodegenerative diseases. Our team have established an autopsy program on deceased PWH to study HIV viral tissue reservoirs and neuropathogenesis. We have collected 459 deceased cases full-body autopsy tissues, including brain tissues to identify viral reservoirs and the effects of cannabis use on the size and distribution of the HIV tissue reservoir since chronic inflammation plays a role in sustaining the reservoirs, and cannabinoids have been shown to have anti-inflammatory effects. We found HIV tissue reservoirs were significantly reduced in cases with cannabis use, and correlates with a decrease in pro-inflammatory cytokines in the viral tissue reservoirs. Critically, our preliminary analysis on the whole brain tissues of PWH found an increase in cell-type specific biological aging of neurons in brains of PWH through DNA methylation epigenetic clock analyses, which paralleled the detection of neuropathology at a younger age in PWH as compared to uninfected individuals. Interestingly, our methylation analysis of various brain tissues also showed PWH who used cannabis have similar cell-type specific biological aging of neurons as uninfected group with similar age, suggesting that cannabis may slow-down aging in PWH possibly due to its anti-inflammatory effect. Therefore, our overall objective of the proposed study is to build onto our preliminary findings by expanding the analysis of autopsied tissues to determine the extent of brain cell-type specific premature aging in PWH, whether cannabis use mitigates such an effect and identify potential mechanisms involved. We hypothesize that HIV- induced chronic inflammation accelerates cell-type specific biological aging programs in PWH, and cannabis use can counteract the premature aging via its anti-inflammatory effects. Our aims are: 1) Determine whether HIV infection enhances cell-type specific epigenetic age and gene expression profiles in the brain regions across the lifespan; 2) Determine whether cannabis use is associated with reduced cell-type specific epigenetic age acceleration, and gene expression alterations across brain regions of PWH; 3) Determine neuroimmune mechanisms linking HIV, epigenetic changes, inflammation, and evaluate the anti-inflammatory role of cannabis. This study will provide a detailed understanding of the spatial distribution of epigenetic changes across age groups in PWH, identify the underlying mechanisms of premature aging in the context of infection, and evaluate cannabis’s effects in reducing premature aging due to HIV infections. Insights from this study will inform targeted interventions to mitigate brain aging in PWH in the U.S. and globally.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $723,353 )
2026	2026	LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER NEW ORLEANS	433 BOLIVAR ST RM 619	NEW ORLEANS	LA	70112	ORLEANS	USA	Drug Use and Addiction Research Programs	000	1	8/24/2026	NEW	$723,353
														Subtotal = $723,353

Grand Total All Awards = $723,353

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Mitigating HIV-Associated Premature Aging Through Cannabinoid-Mediated Anti-Inflammatory Mechanisms

Award Number: R01DA067338

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/01/2026

PERIOD OF PERFORMANCE END DATE: 06/30/2031

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer